top of page

Faraidoon Haghdoost

MD, PhD, Headache and Global Health Researcher

Big Head Pain

PUBLICATIONS

and awards

Faraidoon Haghdoost

The George Institute for Global Health, University of New South Wales (UNSW), Sydney, Australia.

E-mail address: click here

PUBLICATIONS

All Publications

Link to PubMed Page

Selected 10 publications

Haghdoost, F., Gnanenthiran, S.R., Shan, S. et al. The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participants. Eur J Clin Nutr (2024).

Carcel, Cheryl, Faraidoon Haghdoost (co-first), Joanne Shen, Puneet Nanda, Yu Bai, Emily Atkins, Takako Torii-Yoshimura et al. The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis. Cephalalgia 43, no. 6 (2023): 03331024231183166.

Haghdoost F, Puledda F, Garcia-Azorin D, Huessler EM, Messina R, Pozo-Rosich P. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia. 2023 Apr;43(4):3331024231159366.

Messina R, Huessler EM, Puledda F, Haghdoost F, Lebedeva ER, Diener HC. Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis. Cephalalgia. 2023 Mar;43(3):3331024231152169.

Puledda F, Younis S, Huessler EM, Haghdoost F, Lisicki M, Goadsby PJ, Tassorelli C. Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia. 2023 Mar;43(3):3331024231151419.

Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine 2022;17(1):1869-82.

Haghdoost F, Carcel C, Chandrasekhar D, Rodgers A, Delcourt C. The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder. J Neurol. 2021;268(2021):4429-35.

Togha M, Haghdoost F, Khorsha F, Jahromi SR, Ghorbani Z. Body Mass Index and its Association with Migraine Characteristics in Female Patients. Arch Iran Med. 2019;22(10):554-559.

Haghdoost F. Is There an Inverse Relationship Between Migraine and Dietary Sodium Intake? Headache. 2016;56(7):1212-3.

Zandifar A, Asgari F, Haghdoost F, Masjedi SS, Manouchehri N, Banihashemi M, et al. Reliability and Validity of the Migraine Disability Assessment Scale among Migraine and Tension Type Headache in Iranian Patients. Biomed Res Int. 2014;2014:978064.

Last 10 publications

Haghdoost, F., Gnanenthiran, S.R., Shan, S. et al. The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participants. Eur J Clin Nutr (2024).

Carcel, Cheryl, Faraidoon Haghdoost (co-first), Joanne Shen, Puneet Nanda, Yu Bai, Emily Atkins, Takako Torii-Yoshimura et al. The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis. Cephalalgia 43, no. 6 (2023): 03331024231183166.

Haghdoost F, Puledda F, Garcia-Azorin D, Huessler EM, Messina R, Pozo-Rosich P. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia. 2023 Apr;43(4):3331024231159366.

Messina R, Huessler EM, Puledda F, Haghdoost F, Lebedeva ER, Diener HC. Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis. Cephalalgia. 2023 Mar;43(3):3331024231152169.

Puledda F, Younis S, Huessler EM, Haghdoost F, Lisicki M, Goadsby PJ, Tassorelli C. Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia. 2023 Mar;43(3):3331024231151419.

Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine 2022;17(1):1869-82.

Haghdoost, F., Comment on 'Is conventional brain MRI useful for the diagnosis of cluster headache in patients who meet ICHD-3 criteria? Experience in three hospitals in Spain'. J Neurol Sci, 2022: p. 120175.

Haghdoost F, Carcel C, Chandrasekhar D, Rodgers A, Delcourt C. The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder. J Neurol. 2021;268(2021):4429-35.

Haghdoost F, Sacco S. Comment on 'Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale'. J Investig Med. 2020.

Togha M, Haghdoost F, Khorsha F, Jahromi SR, Ghorbani Z. Body Mass Index and its Association with Migraine Characteristics in Female Patients. Arch Iran Med. 2019;22(10):554-559.

Reviewer

Click Publons profile

Total journal reviews: 51

Cephalalgia (13 reviews)
The Journal of Headache and Pain (4 reviews)
Frontiers in Neurology, section Headache and Neurogenic Pain (5 reviews)
Cephalalgia Reports (2 reviews)
Headache, The Journal of Head and Face Pain (1 review)
Pharmacology & Therapeutics (1 review)
Pain Medicine (1 review)
BMC Neurology (3 reviews)
Acta Neurologica Belgica (2 reviews)
Neuropsychiatric Disease and Treatment (1 review)
Frontiers in Psychiatry (1 review)
Frontiers in Pain Research (1 review)
International Journal of Epidemiology (1 review)
Dental Hypothesis (1 review)
Iranian Journal of Neurology (IJNL) (3 reviews)
Iranian Red Crescent Medical Journal (IRCMJ) (7 reviews)
Advanced Biomedical Research (ABR) journal (7 reviews)

AWARDS

iHEAD grant, Awarded funding to attend the 8th iHEAD meeting and the International Headache Congress (IHC2023), in Seoul, South Korea.

Creativity award, one of the trophies for valuable treasures that The George Institute awards selected members at the end of the year.

Free congress participation in EHF2022, by European Headache Federation during the International Headache Congress 2021 (EHF2021), congress photo competition.

IHS Short-stay scholarship by International Headache Society, July 2020

iHEAD grant, Awarded funding to attend the iHEAD meeting and 19th Congress of the International Headache Society (IHC2019), in Dublin, Ireland.

Scientia PhD Scholarship, University of New South Wales (UNSW).

Travel Grant, 17th Migraine Trust International Symposium (MTIS)

ABSTRACT PRESENTATION

Poster presentation, Effects of five major classes of blood pressure lowering drugs and their combinations on headache: a systematic review and network meta-analysis of 402 randomised, double-blind clinical trials. International Headache Congress 2023 (IHC2023), Seoul, South Korea, 14 – 17 September 2023.

E-poster presentation, Effect of transcranial direct current stimulation compared to sham in episodic migraine: systematic review and meta-analysis of randomized controlled trials. International Headache Congress 2021 (IHC2021), virtual meeting due to COVID-19 pandemic, 8 – 12 September 2021.

Oral presentation, Migraine headache frequency and attack triggers during the Coronavirus disease 2019 (COVID‐19) pandemic, Migraine Trust Virtual Symposium 2020 (MTIS2020), Early Career Investigators session, virtual meeting due to COVID-19 pandemic, 3 - 9 October 2020.

Digital presentation, The impact of Coronavirus disease 2019 (COVID‐19) pandemic on migraine management (face-to-face vs. telehealth): Patients’ perspective, Migraine Trust Virtual Symposium 2020 (MTIS2020), virtual meeting due to COVID-19 pandemic, 3 - 9 October 2020.

E-poster presentation, Pilot assessment of the effectiveness and tolerability of low-dose combination blood pressure and cholesterol lowering therapy in migraine patients. A randomized, double-blind, placebo-controlled, 3x3 factorial trial (HAPPy pilot), 14th European Headache Federation Congress (EHF2020), virtual meeting due to COVID-19 pandemic, 29 June - 2 July 2020.

Poster presentation, Anxiety, depression, headache severity and disability: Comparison of male and female migraineurs, 19th Congress of the International Headache Society (IHC2019), Dublin, Ireland, 5-8 September 2019.

E-poster presentation, Body Mass Index and its relationship with disability, severity, duration and frequency of headaches in female migraine patients, 12th European Headache Federation Congress (EHF2018), Florence, Italy, 28-30 September 2018.

Oral presentation, Reliability and Validity of the Migraine Disability Assessment (MIDAS) Questionnaire among Migraine and Tension Type Headache in Iranian Patients, 5th Iranian International headache and first joint headache-pain congress, Iran, Tehran, 11-13 October, 2017.

Poster presentation, Heme oxygenase-1 gene promoter polymorphisms and its association with anthropometric measures and blood pressure in Iranians, 13th Annual Research Congress of Iran`s Medical Sciences Students (ARCIMS) in Babol/ Iran, 9-12 October 2012.

Poster presentation, the effect of quercus brantti gall extract on platelet derived growth factor (PDGF) and fibroblast growth factor (FGF) concentration in skin burn wound fluid in rat, annual research congress of eastern medical sciences students (ARCEMSS) in Mashhad/ Iran, 15-19 November 2011.

Poster presentation, the effect of pistacia atlantica resine extract on platelet derived growth factor (PDGF) and fibroblast growth factor (FGF) concentration in skin burn wound fluid in rat, annual research congress of eastern medical sciences students (ARCEMSS) in Mashhad/ Iran, 15-19 November 2011.

Oral Presentation, the effect of pistacia atlantica resine extract on skin burn wound healing in rat, annual research congress of eastern medical sciences student`s (ARCEMSS) in Mashhad/ Iran, 15-19 November 2011.

Poster presentation, Association between heme oxygenase-1 gene promoter polymorphisms and metabolic syndrome in Iranians, 12th Iranian Congress of Biochemistry & 4th International Congress of Biochemistry and Molecular Biology, Mashhad, Iran, 6-9 September 2011.

ABSTRACT PUBLICATION

Publication of an abstract in Migraine Trust International Symposium (MTIS), as poster in London, United Kingdom, entitled “The effect of salt substitution on headache: a cluster-randomized controlled trial”, September 8-11, 2022.

Publication of an abstract in 17th Migraine Trust International Symposium (MTIS), as poster in London, United Kingdom, entitled “Body Mass Index and its relationship with disability, impact on daily life, severity and frequency of headaches in tension type headache patients”, September 6-9 2018.

Publication of an abstract in International Headache Congress (IHC 2015), as poster in Valencia, Spain, entitled “Prevalence of genetic polymorphism rs11568817 in the promoter region of the gene 5-HTR1B in migraine patients compared with controls”, May 14-17 2015.

Publication of an abstract in 4th European Headache and Migraine Trust International Congress (EHMTIC), as poster in Copenhagen, Denmark, entitled “EHMTI-0058. Association between Ala379Val polymorphism of lipoprotein-associated phospholipase A2 and migraine without aura in an Iranian population”, September 18-21, 2014.

Publication of an abstract in 4th European Headache and Migraine Trust International Congress (EHMTIC), as poster in Copenhagen, Denmark, entitled “EHMTI-0057. Anxiety and depression in migraine patients and their relation with impact, severity and frequency of headaches”, September 18-21, 2014.

Publication of an abstract in 56th Annual Scientific Meeting, American Headache Society as poster in Los Angeles, entitled “Anxiety and Depression in Migraine Patients and Their Relation with Headache-Related Disability”, June 26-29, 2014.

Publication of an abstract in 30th International Congress of Clinical Neurophysiology as poster (P893) in Berlin/Germany, entitled “Association between promoter region of the uPAR (rs344781) gene polymorphism in genetic susceptibility to migraine without aura in Iranian population”, March 19-23, 2014.

Publication of an abstract in 66th American Academia of Neurology (AAN) Annual Meeting as poster (P6.206) in Philadelphia/USA, entitled “Association of the Long Pentraxin PTX3 Gene Polymorphism (rs3815627) with Migraine in Iranian Population”, April 26 through May 3, 2014.

Publication of an abstract in 66th American academia of neurology (AAN) Annual Meeting as poster (P6.208) in Philadelphia/USA, entitled “Investigation of Chemokine Receptor CCR2V64Il Gene Polymorphism and Migraine in Iranian Population”, April 26 through May 3, 2014.

Publication of an abstract in 2013 International Headache Congress as poster (P204) in Boston/USA, entitled “Reliability and Validity of the Migraine Disability Assessment (MIDAS) Questionnaire among Migraine and Tension Type Headache in Iranian Patients”, 27-30 June 2013.

Publication of an abstract in 2013 International Headache Congress as poster (P193) in Boston/USA, entitled “The Psychometric Properties of the Persian Migraine-Specific Quality of Life Questionnaire Version 2.1 (MSQ) in Episodic and Chronic Migraine”, 27-30 June 2013.

Publication of an abstract in 2013 International Headache Congress as poster (P185) in Boston/USA, entitled “Reliability and Validity of the Persian Headache Impact Test (HIT-6) Questionnaire across Migraine and Tension Type Headache”, 27-30 June 2013.

Publication of an abstract in 2013 International Headache Congress as poster (P173) in Boston/USA, entitled “Relation between Vitamin D Receptor Gene Polymorphisms and Migraine without Aura in Iranian Population”, 27-30 June 2013.

bottom of page